NeuroMetrix, Inc. (NURO)
Company Description
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico.
Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies.
The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons.
NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
| Country | United States |
| Founded | 1996 |
| Industry | Health Care Equipment & Supplies |
| Sector | Health Care |
| Employees | 23 |
| CEO | Shai Gozani |
Contact Details
Address:
1000 Winter St Waltham, Massachusetts 02451-1436 United States | |
| Phone | 781 890 9989 |
| Website | neurometrix.com |
Stock Details
| Ticker Symbol | NURO |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | US Dollars |
| CIK Code | 0001289850 |
| CUSIP Number | 641255104 |
| ISIN Number | US6412558073 |
| Employer ID | 04-3308180 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dr. Shai N. Gozani M.D., Ph.D. | Founder, Chairman, Chief Executive Officer, President and Secretary |
| Thomas T. Higgins | Senior Vice President, Chief Financial Officer and Treasurer |
| Dr. Xuan Kong Ph.D. | Chief Data Scientist |
| Susan M. Bell R.N. | Senior Vice President of Population Health and Value Based Care |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 31, 2022 | SD | Specialized disclosure report |
| May 26, 2022 | 4 | Statement of changes in beneficial ownership of securities |
| May 26, 2022 | 4 | Statement of changes in beneficial ownership of securities |
| May 26, 2022 | 4 | Statement of changes in beneficial ownership of securities |
| May 26, 2022 | 4 | Statement of changes in beneficial ownership of securities |
| May 26, 2022 | 4 | Statement of changes in beneficial ownership of securities |
| May 19, 2022 | S-8 | Securities to be offered to employees in employee benefit plans |
| May 3, 2022 | 8-K | Current report |
| Apr 26, 2022 | 10-Q | Quarterly report [Sections 13 or 15(d)] |
| Apr 26, 2022 | 8-K | Current report |